Advances in the Pharmacologic Management of Obesity: An Expert Digest of the Latest Data

Breaking the Silence: Tackling Liver Fibrosis in MASH: Who to Treat With Novel Therapies

Coexisting Comorbidities: Advancing Holistic Care in COPD

Novel Biological Approaches for Enhanced Obesity and Diabetes Management – What's Next?

Latest Advances in mHSPC: An Update From Berlin 2025

Conference Insights: Breaking Developments in ALK-Positive NSCLC and ES-SCLC

Charting the Course for Metastatic Breast Cancer Care: Optimizing First-Line Treatment and Beyond

Paving the Way for Success in Integrating Biosimilars Into Multiple Sclerosis Care: Optimizing Communication

Advancing Personalized Care for Prostate Cancer: Patient-Centered Solutions for mHSPC and nmCRPC

Reshaping Obesity and Diabetes Care With Innovative Multiagonism Concepts

The Hidden Battle: Understanding Chronic Inflammation in Aging People Living With HIV and Comorbidities

Emerging Therapies for MASH: From Theory to Clinical Practice

Interpreting JC Virus Test Results in Multiple Sclerosis Management: Are You Up to Speed?

Targeting Diabesity From Multiple Angles: Future Prospects and Imminent Realities

Neovascular AMD: Optimizing Disease Control for Your Patients

The Hidden Hurdle: Practical Insights on Drug-Drug Interactions in Prostate Cancer Management

Managing Diabetic Macular Edema in Clinical Practice

Shaping the Future: Expert Insights on Perioperative Immunotherapy for Gastric/GEJ Cancers

Thyroid Eye Disease: How to Use Targeted Immunotherapy in Clinical Practice

Immunopathogenesis of IgAN and the Evolving Treatment Landscape: A Focus on the B-Cell Pathway